Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The available data include two acute oral toxicity studies in rats.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1964
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Qualifier:
no guideline followed
Principles of method if other than guideline:
Principle of test: LD50 test in the rat.
LD50s were calculated using the Litchfield and Wilcoxon method. No further details reported.
GLP compliance:
no
Test type:
other: Not specified
Limit test:
no
Specific details on test material used for the study:
The test substance was reported as 'dihydroanethole (1-methoxy-4-propylbenzene)'. No further details reported.
Species:
rat
Strain:
Osborne-Mendel
Sex:
male/female
Details on test animals or test system and environmental conditions:
Young adults, fasted for approximately 18 hours prior to treatment had access to water at all times and food was replaced after dosing.
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
VEHICLE
No vehicle was used in this study. The test substance was adminsitered undiluted.

CLASS METHOD
- Rationale for the selection of the starting dose: Justification of the starting dose was not provided.
Doses:
No details reported.
No. of animals per sex per dose:
Groups of 10 rats (5 males and 5 females).
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: The typical observation period of 2 weeks after adminsitration. If no effects were seen during early phases of observation, animals were only monitored for 1 week.
- Necropsy of survivors performed: Not specified
- Other examinations performed: clinical signs, body weight
Statistics:
LD50s were calculated using the Litchfield and Wilcoxon method.
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
4 400 mg/kg bw
Based on:
test mat.
95% CL:
1.9
Mortality:
Death time = 4 hrs - 3 days
Clinical signs:
other: Depression, wet posterior.
Gross pathology:
No details reported.
Other findings:
No details reported.
Interpretation of results:
GHS criteria not met
Conclusions:
An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
Executive summary:

An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1964
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Qualifier:
no guideline available
Principles of method if other than guideline:
Principle of test: LD50 test in the rat.
LD50's calcuated using the Litchfield and Wilcocon method. No further details reported.
GLP compliance:
no
Test type:
fixed dose procedure
Limit test:
no
Specific details on test material used for the study:
The test substance is reported under the alternative name 'dihydroanethole (1-methoxy-4-propylbenzene)'. No further details reported.
Species:
rat
Strain:
other:
Remarks:
Osborne Mendel or Sherman strain used (specific strain details not reported).
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Not reported
- Females (if applicable) nulliparous and non-pregnant: Not reported
- Age at study initiation: Reported as 'young'. No further details available.
- Weight at study initiation: 180-350 g
- Fasting period before study: 18 hours
- Housing: Not reported
- Diet (e.g. ad libitum): Not reported
- Water (e.g. ad libitum): Not reported
- Acclimation period: Not reported

No details on evironmental conditions were reported.
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
VEHICLE
The test item was administered undiluted. No vehicle was used.

MAXIMUM DOSE VOLUME APPLIED: Not reported

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: No starting dose justification was provided.
Doses:
No details reported
No. of animals per sex per dose:
5
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: Rats were observed until survivors retunred to normal weight and appearance.
- Frequency of observations and weighing: No details reported
- Necropsy of survivors performed: No details reported
- Other examinations performed: clinical signs and body weight
Statistics:
LD50s were computed by Litchfield and Wilcoxon method.
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
4 400 mg/kg bw
95% CL:
1.9
Mortality:
Death time: 4 hrs - 3 days
Clinical signs:
other: Depression, porphyrin-like deposit around eyes and nose, wet posterior
Gross pathology:
No details reported.
Other findings:
In a follow-up study, histopathological examination fo the liver of rats (3/sex/dose) administered dihydroanethole an acute dose of 1470 mg/kg. Results gave a rating of 0.5 = liver had 1 or 2 necrotic lesions grayish or yellow in colour.
Interpretation of results:
GHS criteria not met
Conclusions:
An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
Executive summary:

An oral LD50  of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
4 400 mg/kg bw
Quality of whole database:
Both of the studies are considered to have a reliability score of 2.

Additional information

Justification for classification or non-classification

An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).